Transfer of the interleukin-1 receptor antagonist gene into rat liver abrogates hepatic ischemia-reperfusion injury

Transplantation

Volumn 74, Issue 10, 2002, Pages 1434-1441

  Harada, Hirohisa ^a   Wakabayashi, Go ^a   Takayanagi, Atsushi ^a   Shimazu, Motohide ^a   Matsumoto, Kenji ^a   Obara, Hideaki ^a   Shimizu, Nobuyoshi ^a   Kitajima, Masaki ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE TRANSFER; HUMAN; HUMAN CELL; LIVER INJURY; LIVER ISCHEMIA; MALE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SURVIVAL RATE; TRANSGENE;

EID: 0036851360     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200211270-00016     Document Type: Article

References (28)

1. Keefee EB. Liver transplantation: Current status and novel approaches to liver replacement. Gastroenterology 2001; 120: 749.
2. Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reperfusion injury. Am J Surg 2001; 181: 160.
3. Shito M, Wakabayashi G, Ueda M, et al. Interleukin 1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat. Transplantation 1997; 63: 143.
4. Shirasugi N, Wakabayashi G, Shimazu M, et al. Up-regulation of oxygen-derived free radicals by interleukin-1 in hepatic ischemia/reperfusion injury. Transplantation 1997; 64: 1398.
5. Suzuki S, Toledo-Pereyra LH. Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J Surg Res 1994; 57: 253.
6. Rangarajan PN, Vatsara PG, Ashok MS, et al. Non-viral ex vivo hepatic gene transfer by in situ lipofection of liver and intraperitoneal transplantation of hepatocytes. Gene 1997; 190: 217.
7. Sumitomo M, Tachibana M, Hayakawa M, et al. Overexpression of IL-1ra gene up-regulates interleukin-1β converting enzyme (ICE) gene expression: Possible mechanism underlying IL-1β-resistance of cancer cells. Br J Cancer 1999; 81: 277.
8. Eisenberg SP, Evans RJ, Arend WP, et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990; 343: 341.
9. Carter DB, Deibel MR Jr, Dunn CJ, et al. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 1990; 344: 633.
10. Miyake S, Makimura M, Kanegae Y, et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci U S A 1996; 93: 1320.
11. Clark BD, Bedrosian I, Schindler R, et al. Detection of interleukin 1 alpha and 1 beta in rabbit tissues during endotoxemia using sensitive radioimmunoassays. J Appl Physiol 1991; 71: 2412.
12. Herz J, Gerard RD. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci U S A 1993; 90: 2812.
13. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627.
14. Wakabayashi G, Gelfand JA, Burke JF, et al. A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits. FASEB J 1991; 5: 338.
15. Arend WP, Welgus HG, Thompson RC, et al. Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest 1990; 85: 1694.
16. Dinarello CA, Gelfand JA, Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993; 269: 1829.
17. Drazan KE, Csete ME, Shen XD, et al. A. Hepatic function is preserved following liver-directed, adenovirus-mediated gene transfer. J Surg Res 1995; 59: 299.
18. Xing Z, Ohkawara Y, Jordana M, et al. Adenoviral vector-mediated interleukin-10 expression in vivo: Intramuscular gene transfer inhibits cytokine responses in endotoxemia. Gene Ther 1997; 4: 140.
19. Ilan Y, Prakash R, Davidson A, et al. Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors. J Clin Invest 1997; 99: 1098.
20. Tilg H, Trehu E, Atkins MB, et al. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994; 83: 113.
21. Leon LR, White AA, Kluger MJ. Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice. Am J Physiol 1998; 275: R269.
22. Camargo CA Jr, Madden JF, Gao W, et al. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997; 26: 1513.
23. Tacchini L, Radice L, Pogliaghi G, et al. Differential activation of heat shock and nuclear factor kappa-B transcription factors in postischemic reperfused rat liver. Hepatology 1997; 26: 186.
24. Bandara G, Mueller GM, Galea-Lauri J, et al. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci U S A 1993; 90: 10764.
25. Jiang Y, Genant HK, Watt I, et al. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: Radiologic progression and correlation of Genant and Larsen scores. Arthritis Rheum 2000; 43: 1001.
26. Pan RY, Chen SL, Xiao X, et al. Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist. Arthritis Rheum 2000; 43: 289.
27. Xing X, Yujiao CJ, Hung M. Preclinical and clinical study of HER-2/neu-targeting cancer gene therapy. Adv Drug Deliv Rev 1998; 30: 219.
28. Stedman H, Wilson JM, Finke R, et al. Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: Alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors. Hum Gene Ther 2000; 11: 777.